MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rens-Domiano, S.
Right arrow Articles by Reisine, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rens-Domiano, S.
Right arrow Articles by Reisine, T.

Pharmacological properties of two cloned somatostatin receptors

S Rens-Domiano, SF Law, Y Yamada, S Seino, GI Bell and T Reisine

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104.

Previous studies have shown that at least two subtypes of somatostatin (SRIF) receptors (SRIF1 and SRIF2) are expressed in mammalian cells. SRIF1 receptors have high affinity for MK 678, whereas SRIF2 receptors have no affinity for MK 678 but selectively bind peptides with structures similar to that of CGP 23996. Recently, two SRIF receptor genes have been cloned from human and mouse genomic libraries. In the present study, the pharmacological properties of these two cloned SRIF receptors, expressed in Chinese hamster ovary (CHO) cells, were investigated, to determine whether they have any similarity to the previously described SRIF1 and SRIF2 receptor subtypes. Both cloned receptors could be labeled with 125I-Tyr11-SRIF and exhibited high affinity for SRIF. The SSTR1 receptor could also bind CGP 23996-like compounds but not MK 678. In contrast, the SSTR2 receptor was insensitive to CGP 23996-like compounds but bound MK 678 with high affinity. These findings indicate that the peptide specificities of the cloned SSTR1 and SSTR2 receptors differ from each other. Pretreatment of CHO cells expressing the two cloned SRIF receptors with SRIF abolished high affinity agonist binding to the cloned SSTR2 receptor but not the cloned SSTR1 receptor. Agonist binding to SSTR1 receptors was not significantly affected by guanosine-5'-)-(3-thiotriphosphate) or pertussis toxin pretreatment, whereas agonist binding to SSTR2 receptors was inhibited by both treatments. These findings suggest that SSTR2 receptors can be regulated and they associate with pertussis toxin-sensitive guanine nucleotide-binding proteins, whereas SSTR1 receptors do not. SRIF is a potent inhibitor of adenylyl cyclase activity in mammalian cells. However, neither the cloned SSTR2 nor SSTR1 receptor mediated SRIF inhibition of adenylyl cyclase activity in stably transformed CHO cells or COS-1 cells transiently expressing the cloned receptors, suggesting that neither cloned receptor couples to adenylyl cyclase. The results of these studies indicate that the two cloned SRIF receptors have different pharmacological properties. The characteristics of the cloned SSTR2 receptor are similar to those of the previously described SRIF1 receptor, and the characteristics of the cloned SSTR1 receptor are similar to those of the previously described SRIF2 receptor.

Volume 42, Issue 1, pp. 28-34, 07/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
S. Arena, A. Pattarozzi, A. Corsaro, G. Schettini, and T. Florio
Somatostatin Receptor Subtype-Dependent Regulation of Nitric Oxide Release: Involvement of Different Intracellular Pathways
Mol. Endocrinol., January 1, 2005; 19(1): 255 - 267.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. J. Hofland and S. W. J. Lamberts
The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance
Endocr. Rev., February 1, 2003; 24(1): 28 - 47.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Schwarzler, H.-J. Kreienkamp, and D. Richter
Interaction of the Somatostatin Receptor Subtype 1 with the Human Homolog of the Shk1 Kinase-binding Protein from Yeast
J. Biol. Chem., March 24, 2000; 275(13): 9557 - 9562.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Baumeister, M. Wegner, D. Richter, and W. Meyerhof
Dual Regulation Of Somatostatin Receptor Subtype 1 Gene Expression By Pit-1 In Anterior Pituitary GH3 Cells
Mol. Endocrinol., February 1, 2000; 14(2): 255 - 271.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Tomura, H. Itoh, K. Sho, K. Sato, M. Nagao, M. Ui, Y. Kondo, and F. Okajima
beta gamma Subunits of Pertussis Toxin-sensitive G Proteins Mediate A1 Adenosine Receptor Agonist-induced Activation of Phospholipase C in Collaboration with Thyrotropin. A NOVEL STIMULATORY MECHANISM THROUGH THE CROSS-TALK OF TWO TYPES OF RECEPTORS
J. Biol. Chem., September 12, 1997; 272(37): 23130 - 23137.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chen, V. D. Fitzpatrick, R. L. Vandlen, and A. H. Tashjian Jr.
Both Overlapping and Distinct Signaling Pathways for Somatostatin Receptor Subtypes SSTR1 and SSTR2 in Pituitary Cells
J. Biol. Chem., July 25, 1997; 272(30): 18666 - 18672.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. B. Reardon, P. Dent, S. L. Wood, T. Kong, and T. W. Sturgill
Activation In Vitro of Somatostatin Receptor Subtypes 2, 3, or 4 Stimulates Protein Tyrosine Phosphatase Activity in Membranes from Transfected Ras-Transformed NIH 3T3 Cells: Coexpression with Catalytically Inactive SHP-2 Blocks Responsiveness
Mol. Endocrinol., July 1, 1997; 11(8): 1062 - 1069.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. W. Hipkin, J. Friedman, R. B. Clark, C. M. Eppler, and A. Schonbrunn
Agonist-induced Desensitization, Internalization, and Phosphorylation of the sst2A Somatostatin Receptor
J. Biol. Chem., May 23, 1997; 272(21): 13869 - 13876.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y.-Z. Gu and A. Schonbrunn
Coupling Specificity between Somatostatin Receptor sst2A and G Proteins: Isolation of the Receptor-G Protein Complex with a Receptor Antibody
Mol. Endocrinol., May 1, 1997; 11(5): 527 - 537.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
D. Nouel, G. Gaudriault, M. Houle, T. Reisine, J.-P. Vincent, J. Mazella, and A. Beaudet
Differential Internalization of Somatostatin in COS-7 Cells Transfected with SST1 and SST2 Receptor Subtypes: A Confocal Microscopic Study Using Novel Fluorescent Somatostatin Derivatives
Endocrinology, January 1, 1997; 138(1): 296 - 306.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. S. Murthy, D. H. Coy, and G. M. Makhlouf
Somatostatin Receptor-mediated Signaling in Smooth Muscle. ACTIVATION OF PHOSPHOLIPASE C-beta 3 BY Gbeta gamma AND INHIBITION OF ADENYLYL CYCLASE BY Galpha i1 AND Galpha o
J. Biol. Chem., September 20, 1996; 271(38): 23458 - 23463.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Liapakis, D. Fitzpatrick, C. Hoeger, J. Rivier, R. Vandlen, and T. Reisine
Identification of Ligand Binding Determinants in the Somatostatin Receptor Subtypes 1and 2
J. Biol. Chem., August 23, 1996; 271(34): 20331 - 20339.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Buisson, L. Laflamme, S. P. Bottari, M. de Gasparo, N. Gallo-Payet, and M. D. Payet
A G Protein Is Involved in the Angiotensin AT(2) Receptor Inhibition of the T-Type Calcium Current in Non-differentiated NG108-15 Cells
J. Biol. Chem., January 27, 1995; 270(4): 1670 - 1674.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics